Tumors have a complex ecosystem in which behavior and fate are determined by the interaction of diverse cancerous and noncancerous cells at local and systemic levels. A number of studies indicate that various immune cells participate in tumor development (Fig. 1). In this review, we will discuss interactions among T lymphocytes (T cells), B cells, natural killer (NK) cells, dendritic cells (DCs), tumor-associated macrophages (TAMs), neutrophils, and myeloid-derived suppressor cells (MDSCs). In addition, we will touch upon attempts to either use or block subsets of immune cells to target cancer.
CITATION STYLE
Zhang, J., Späth, S. S., Weissman, S. M., & Katz, S. G. (2020). An overview of advances in cell-based cancer immunotherapies based on the multiple immune-cancer cell interactions. In Methods in Molecular Biology (Vol. 2097, pp. 139–171). Humana Press Inc. https://doi.org/10.1007/978-1-0716-0203-4_10
Mendeley helps you to discover research relevant for your work.